Literature DB >> 7228396

Binding of radiolabeled Staphylococcus aureus delta-toxin to human erythrocytes.

F S Nolte, F A Kapral.   

Abstract

The addition f [3H]isoleucine to a chemically defined medium resulted in the production of delta-toxin (DT) with a high specific radioactivity (0.47 microCi/mg). The purified tritium-labeled toxin ([3H]DT) was found to migrate in sodium dodecyl sulfate-polyacrylamide gel electrophoresis as a single band with a molecular weight of 1,600. Upon electrofocusing, [3H]DT yielded one major peak (pI = 5.90) and two minor peaks (pI = 5.10, 6.95) of radioactivity. The percentage of [3H]DT associated with pelleted fractions of intact erythrocytes or erythrocyte ghosts remained fairly constant over a 100-fold range of toxin concentrations. Erythrocyte ghosts, however, bound more [3H]DT than did intact erythrocytes when exposed to the same concentration of toxin. Erythrocytes maintained in isotonic sucrose were more susceptible to toxin than erythrocytes suspended in saline, but did not bind more [3H]DT. The binding of [3H]DT to erythrocyte ghosts was found to be temperature dependent from 0 to 20 degrees C but was constant from 20 to 50 degrees C.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7228396      PMCID: PMC351428          DOI: 10.1128/iai.31.3.1086-1093.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

1.  The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes.

Authors:  J T DODGE; C MITCHELL; D J HANAHAN
Journal:  Arch Biochem Biophys       Date:  1963-01       Impact factor: 4.013

2.  Staphylococcal toxins. II. Factors affecting hemolysis by delta-lysin.

Authors:  A W JACKSON; R M LITTLE
Journal:  Can J Microbiol       Date:  1958-10       Impact factor: 2.419

3.  Purification and properties of staphylococcal delta hemolysin.

Authors:  A S Kreger; K S Kim; F Zaboretzky; A W Bernheimer
Journal:  Infect Immun       Date:  1971-03       Impact factor: 3.441

4.  Assay of staphylococcal delta-haemolysin with fish erythrocytes.

Authors:  L P Chao; T H Birkbeck
Journal:  J Med Microbiol       Date:  1978-08       Impact factor: 2.472

5.  Molecular weight analysis of oligopeptides by electrophoresis in polyacrylamide gel with sodium dodecyl sulfate.

Authors:  R T Swank; K D Munkres
Journal:  Anal Biochem       Date:  1971-02       Impact factor: 3.365

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Staphylococcal delta-hemolysin inhibits cellular binding of epidermal growth factor and induces arachidonic acid release.

Authors:  K Umezawa; I B Weinstein; W V Shaw
Journal:  Biochem Biophys Res Commun       Date:  1980-05-30       Impact factor: 3.575

8.  Staphylococcal delta hemolysin: purification and characterization.

Authors:  H S Kantor; B Temples; W V Shaw
Journal:  Arch Biochem Biophys       Date:  1972-07       Impact factor: 4.013

9.  Effect of fatty acids on Staphylococcus aureus delta-toxin hemolytic activity.

Authors:  F A Kapral
Journal:  Infect Immun       Date:  1976-01       Impact factor: 3.441

10.  Purification and characterization of an immunologically distinct delta-hemolysin from a canine strain of Staphylococcus aureus.

Authors:  W H Turner
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

View more
  3 in total

1.  Immunogenicity of Staphylococcus aureus delta-toxin.

Authors:  F S Nolte; F A Kapral
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

2.  Studies on the interaction of staphylococcal delta-haemolysin with isolated islets of Langerhans.

Authors:  N G Morgan; W Montague
Journal:  Biochem J       Date:  1982-04-15       Impact factor: 3.857

3.  Hydrophobic interaction chromatography of Staphylococcus aureus delta-toxin.

Authors:  F S Nolte; F A Kapral
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.